| Income Statement |
| Operating Expenses | 2.62M |
|
| Research and Development Expense | 1.48M |
| Selling, General and Administrative Expense | 1.14M |
| Operating Income | -2.62M |
| Net Income | -1.83M |
| Net Income Common Stock | -1.83M |
| Net Income Common Stock (USD) | -1.83M |
| Consolidated Income | -1.83M |
| Earnings per Basic Share | -0.09 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.09 |
| Earning Before Interest & Taxes (EBIT) | -1.83M |
| Earning Before Interest & Taxes (USD) | -1.83M |
| Weighted Average Shares | 19.31M |
| Weighted Average Shares Diluted | 19.31M |
| Balance Sheet |
| Cash and Equivalents | 11.92M |
| Cash and Equivalents (USD) | 11.92M |
| Trade and Non-Trade Receivables | 1.62M |
| Current Assets | 14.59M |
| Total Assets | 14.59M |
| Current Liabilities | 2.42M |
| Total Liabilities | 2.42M |
| Accumulated Retained Earnings (Deficit) | -464.19M |
| Shareholders Equity | 12.17M |
| Shareholders Equity (USD) | 12.17M |
| Deferred Revenue | 591.31K |
| Trade and Non-Trade Payables | 1.83M |
| Cash Flow |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.72M |
| Net Cash Flow from Operations | -3.72M |
| Share Based Compensation | 195.74K |